ACLX
Price:
$115.07
Market Cap:
$6.73B
Arcellx, Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering immunotherapeutic solutions for patients battling cancer and other intractable diseases. A cornerstone of their pipeline is CART-ddBCMA, an advanced ddCAR product candidate currently undergoing a Phase 1 clinical trial. This investigational treatment targets individuals suffering from relapsed or refractory multiple myeloma (MM). Beyond their lead candidate, Arcellx is also advancing ACLX-001, an immunotherapy composed of ARC-T cells and bi-valent SparX proteins engineered to combat r/r MM by targeting BCMA. Their development efforts extend to ACLX-002 and ACLX-003, designed to address relapsed or refractory a...[Read more]
Industry
Biotechnology
IPO Date
2022-02-04
Stock Exchange
NASDAQ
Ticker
ACLX
According to Arcellx, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -28.27. This represents a change of 64.14% compared to the average of -17.22 of the last 4 quarters.
The mean historical PE Ratio of Arcellx, Inc. over the last ten years is -19.01. The current -28.27 PE Ratio has changed 14.77% with respect to the historical average. Over the past ten years (40 quarters), ACLX's PE Ratio was at its highest in in the December 2023 quarter at 36.51. The PE Ratio was at its lowest in in the March 2024 quarter at -119.61.
Average
-19.01
Median
-13.72
Minimum
-38.34
Maximum
-0.33
Discovering the peaks and valleys of Arcellx, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 9.55%
Maximum Annual PE Ratio = -0.33
Minimum Annual Increase = -64.63%
Minimum Annual PE Ratio = -38.34
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -16.02 | -58.22% |
| 2024 | -38.34 | 1.56% |
| 2023 | -37.76 | 421.60% |
| 2022 | -7.24 | -16.41% |
| 2021 | -8.66 | -24.23% |
| 2020 | -11.43 | -64.63% |
| 2019 | -32.31 | 9.55% |
The current PE Ratio of Arcellx, Inc. (ACLX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-30.71
5-year avg
-21.60
10-year avg
-19.01
Arcellx, Inc.’s PE Ratio is less than Alkermes plc (48.38), less than NewAmsterdam Pharma Company N.V. (-16.48), less than Akero Therapeutics, Inc. (-14.61), greater than Protagonist Therapeutics, Inc. (-62.63), greater than Arrowhead Pharmaceuticals, Inc. (-38.23), less than Kymera Therapeutics, Inc. (-25.26), less than Viking Therapeutics, Inc. (-7.34), less than Immunovant, Inc. (-12.71), less than CRISPR Therapeutics AG (-8.70), less than Vaxcyte, Inc. (-7.47),
| Company | PE Ratio | Market cap |
|---|---|---|
| 48.38 | $7.50B | |
| -16.48 | $3.49B | |
| -14.61 | $4.50B | |
| -62.63 | $7.26B | |
| -38.23 | $11.52B | |
| -25.26 | $7.44B | |
| -7.34 | $3.53B | |
| -12.71 | $7.26B | |
| -8.70 | $5.22B | |
| -7.47 | $7.43B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcellx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arcellx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Arcellx, Inc.'s PE Ratio?
How is the PE Ratio calculated for Arcellx, Inc. (ACLX)?
What is the highest PE Ratio for Arcellx, Inc. (ACLX)?
What is the 3-year average PE Ratio for Arcellx, Inc. (ACLX)?
What is the 5-year average PE Ratio for Arcellx, Inc. (ACLX)?
How does the current PE Ratio for Arcellx, Inc. (ACLX) compare to its historical average?